Customise Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorised as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

For more information on how Google's third-party cookies operate and handle your data, see: Google Privacy Policy

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Performance cookies are used to understand and analyse the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customised advertisements based on the pages you visited previously and to analyse the effectiveness of the ad campaigns.

Other uncategorised cookies are those that are being analysed and have not been classified into a category as yet.

No cookies to display.

PHARMASEAL and Mayet Announce Strategic Integration Partnership

April 9, 2025

PHARMASEAL and Mayet Announce Strategic Integration Partnership

NOTTINGHAM, April 9, 2025 – PHARMASEAL, a leading provider of enterprise clinical trial management solutions (unified CTMS/eTMF) for global life sciences organizations and Mayet, a leading vendor management software (VMS) company specializing in clinical trial vendor management, compliance tracking, and intelligent automation, have announced a strategic integration partnership to enhance efficiency and compliance in clinical trial process and vendor management..

This collaboration will integrate PHARMASEAL’s innovative Engility® trial management system with Mayet’s vendor management solution. By bridging these platforms, sponsors, CROs, and research sites will benefit from streamlined trial execution, improved vendor management and regulatory compliance, with enhanced data accuracy.

“Together, we are enabling more integrated technology that combine powerful solutions that improves trial management, vendor oversight and compliance whilst offering choice to our customers,” said Daljit Cheema, CEO of PHARMASEAL.

Mayet, CEO, Tom Lazenby, echoed this sentiment, stating, “The integration partnership between Mayet and PHARMASEAL gives clinical trial teams complete visibility across vendor performance and trial operations in one platform. This VMS-CTMS connection helps Sponsors and CROs track risks, maintain compliance, and speed up trials without switching between systems. By combining these essential tools, we’re making clinical trials faster and more reliable while helping research teams stay on budget.”

PHARMASEAL and Mayet will begin rolling out the integrated solution in 2025 with early adopters gaining access to enhanced functionality that simplifies clinical trial management.

Coming soon! Chief Product Officer Ricky Lakhani and Mayet’s CEO Tom Lazenby will host a podcast, “Strategic Trial Management: Breaking Down Silos for Better Outcomes,” exploring how unified systems eliminate blind spots, enable cross-functional collaboration, and drive data-powered decisions for scaling clinical trial operations. Stay tuned for more details! For more information about the integration and partnership and the upcoming podcast, please visit pharmseal.co for more information

About PHARMASEAL
PHARMASEAL International Ltd, established in 2016, was founded with a vision to create a unified trial management platform that supports global life science organizations in managing clinical trials aimed at improving human health. The company’s team of clinical technology experts designed and developed the Engility® Trial Management platform to alleviate the burdens of clinical operations, enhance collaboration and oversight, and provide a unified suite that boosts clinical operations productivity. The Engility platform is engineered on a modern cloud architecture and designed to scale efficiently for all types of trials.

About Mayet
Mayet is a vendor management company that optimizes clinical trial operations by streamlining compliance tracking, reducing administrative burden, and improving collaboration between research stakeholders and service providers. Its adaptive technology supports continuous process improvement, providing sponsors, CROs, and research sites with actionable insights for data-driven outsourcing in clinical research. For more details visit Mayetrx.com

Media Contact:
Sally Vernon
Marketing
PHARMASEAL
sally.vernon@pharmaseal.co